Page last updated: 2024-08-16

opc 12759 and misoprostol

opc 12759 has been researched along with misoprostol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Arakawa, T; Sugimori, S; Watanabe, T1
Amagase, K; Satoh, H; Takeuchi, K1
Cho, CS; Kang, YM; Kim, JH; Kim, SK; Lee, DH; Lee, SK; Lee, ST; Lee, YC; Park, SH; Park, W; Park, YW; Rew, JS; Yoo, WH1
Chang, DK; Hong, SN; Kim, ER; Kim, HS; Kim, K; Kim, TJ; Kim, YH; Lee, YC1

Reviews

1 review(s) available for opc 12759 and misoprostol

ArticleYear
[Side effects of gastric muco-protective agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Adjuvants, Pharmaceutic; Alanine; Alprostadil; Aluminum; Anti-Ulcer Agents; Diterpenes; Drug Interactions; Gastric Acid; Gastric Emptying; Humans; Hydrogen-Ion Concentration; Misoprostol; Quinolones; Sulpiride; Tranexamic Acid

2007

Trials

1 trial(s) available for opc 12759 and misoprostol

ArticleYear
Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
    Gut and liver, 2014, Volume: 8, Issue:4

    Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Butanones; Diclofenac; Double-Blind Method; Drug Administration Schedule; Gastric Mucosa; Humans; Meloxicam; Middle Aged; Misoprostol; Nabumetone; Quinolones; Stomach Ulcer; Thiazines; Thiazoles; Treatment Outcome

2014

Other Studies

3 other study(ies) available for opc 12759 and misoprostol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 348, Issue:2

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines

2014
Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.
    Scientific reports, 2019, 08-12, Volume: 9, Issue:1

    Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cohort Studies; Female; Flavonoids; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemoglobins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Misoprostol; Osteoarthritis; Proton Pump Inhibitors; Quinolones; Treatment Outcome

2019